UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047475
Receipt number R000054084
Scientific Title A multicenter prospective randomized controlled trial of the usefulness of RDI for injection in esophageal ESD
Date of disclosure of the study information 2022/04/14
Last modified on 2023/10/15 21:41:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter prospective randomized controlled trial of the usefulness of RDI for injection in esophageal ESD

Acronym

Esophageal RDI study

Scientific Title

A multicenter prospective randomized controlled trial of the usefulness of RDI for injection in esophageal ESD

Scientific Title:Acronym

Esophageal RDI study

Region

Japan


Condition

Condition

superficial esophageal cancer

Classification by specialty

Gastroenterology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether using RDI to identify deep blood vessels and avoiding them during injection for esophageal ESD can prevent bleeding and hematoma formation associated with injection.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Major bleeding or not

Key secondary outcomes

1. The number of blood vessels observed around the lesion
2. Frequency of major/minor bleeding associated with injection
3. The number of hematomas per unit length of the mucosal resection line
4. Procedure time
5. En-block resection rate
6. R0 resection rate
7. Adverse events


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

During mucosal injection in esophageal ESD, use RDI to identify the presence of blood vessels and avoid them during injection.

Interventions/Control_2

During mucosal injection in esophageal ESD, white light alone is used for injection without RDI.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients over 20 years old who will undergo ESD for lesions diagnosed or suspected to be superficial esophageal cancer at Keio University Hospital and collaborating hospitals. We don't necessarily need a tissue diagnosis.

Key exclusion criteria

(1) Cases in which antithrombotic drug withdrawal is not feasible according to guidelines (Guidelines for Gastrointestinal Endoscopy for Patients on Antithrombotic Medications)
(2) Lesions less than 5 mm or more than 50 mm in size at the time of preoperative evaluation.
(3) Cases in which a histological type other than squamous cell carcinoma, such as Barrett's adenocarcinoma, is suspected.
(4) Cases of esophagogastric junction carcinoma in which the resection line does not settle within the squamous epithelium
(5) Cases in which the resection is full circumferential
(6) Cases after surgical treatment
(7) Cases involving scars after endoscopic treatment
(8) Cases involving radiotherapy irradiation areas
(9) Patients with coagulation disorders
(10) Patients on continuous hemodialysis
(11) Patients with non-compensated liver cirrhosis
(12) Cases that investigators consider inappropriate to conduct this study

Target sample size

130


Research contact person

Name of lead principal investigator

1st name Motohiko
Middle name
Last name Kato

Organization

Cancer center

Division name

Division of research and development for minimally invasive treatment

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

03-3353-1211

Email

motohikokato@keio.jp


Public contact

Name of contact person

1st name Kurato
Middle name
Last name Miyazaki

Organization

Cancer center

Division name

Division of research and development for minimally invasive treatment

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

03-3353-1211

Homepage URL


Email

k.miyazaki30417@gmail.com


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

1. National Hospital Organization Tokyo Medical Center
2. Saitama City Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University Hospital

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 03 Month 21 Day

Date of IRB

2022 Year 04 Month 05 Day

Anticipated trial start date

2022 Year 04 Month 18 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 04 Month 13 Day

Last modified on

2023 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054084


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name